| Nombre | ANGELES CONCEPCION TECALCO CRUZ |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | BIOLOGÍA MOLECULAR |
| Especialidad | BIOLOGIA MOLECULAR |
| CVU | 176975 |
| Institución | |
|---|---|
| Dependencia | DEL VALLE UNIVERSIDAD AUTONOMA DE LA CIUDAD DE MEXICO |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2025 |
| Fin: 31/12/2029 |
Publicaciones ORCID
- 2026
- Identification of proteases associated with glioblastoma and their modulation by interferon-gamma signaling. European cytokine network
- 2025
- ADAMTS-8 and kallikrein-related peptidases 10 and 5 proteases also have a tumor suppression role WORLD JOURNAL OF CLINICAL ONCOLOGY
- Molecular Interplay of ISG15/ISGylation in Neuropathologies CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
- 2024
- Deregulation of interferon-gamma receptor 1 expression and its implications for lung adenocarcinoma progression WORLD JOURNAL OF CLINICAL ONCOLOGY
- Molecular interplay between the upregulated levels of Sad1 and UNC84 Domain Containing 2 (SUN2) and gene expression in medulloblastoma cells MOLECULAR BIOLOGY REPORTS
- Over 60 years of neurochemistry, the heritage of Dr. Ricardo Tapia FRONTIERS IN MOLECULAR NEUROSCIENCE
- 2023
- Protein ISGylation: a posttranslational modification with implications for malignant neoplasms Exploration of Targeted Anti-tumor Therapy
- Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer's disease in aging women METABOLIC BRAIN DISEASE
- 2022
- Free ISG15 and Protein ISGylation Emerging in SARS-CoV-2 Infection CURRENT DRUG TARGETS
- ISG15 and ISGylation: Emergence in the cytoskeleton dynamic and tumor microenvironment BIOCELL